INTRODUCTION
Nagamine and Ohkuma reported the presence of alkaline phosphatase-liked immunoglobulin G in the serum of a patient with multiple epiphyseal dysplasia in 1975.1) Since that time, numerous studies have dealt with alkaline phosphatase-immunoglobulin complexes (ALP-Ig). The heterogeneous molecular weight of these complexes have been described as 550kD,2) 280kD,3) 500kD4) or 900kD.5) These results have been discussed from the view that the complex consisted of one or more enzymes against one immunoglobulin molecule.
On the other hand, some immunoglobulins which associated with the complexes of serum enzyme and immunoglobulin have been considered as autoantibodies. 6, 7) In such cases, these complexes have been accepted as immune complexes.
Fragments of complement component C3, such as
C3c and/or C3d bind to many kinds of immune complexes, and many circulating immune complexes carry these fragments.8,9) Therefore, ALPIg may bind other substances such as complement components.
In the present study, ALP-Ig from two patients were analyzed by counterimmunoelectrophoresis using anti-human antibodies, in order to determine the association of complement components.
MATERIALS AND METHODS

1) Materials
Serum samples were obtained from two patients at our facility; one, a 70-year-old male with pancreatic cancer, and the other, a 72-year-old and used within one week.
2) Electrophoretic studies of ALP isozymes ALP isozymes were examined by cellulose acetate membrane electrophoresis and counterimmunoelectrophosesis (CIE) as described previously.10) ALP activity on the membrane was visualized by incubation with 5-bromo-3-indolylphosphate. Rabbit anti-human IgA, IgG, IgM, kappa light chain, lambda light chain, and anti-complement C1q and anti-complement C3c were purchased from Dako-Immunoglobulins Co. Ltd. (Denmark). (Hoe-chst Japan Ltd., Japan).
4) Amino acid inhibition assays
The final concentrations of amino acids were as follows:
Amino acid inhibition and heat inactivation assays were performed using 5mmol/l p-nitrophenylphosphate described in the assay of ALP acitivity. In one case, ALP activity was observed in the form of a diffuse belt at the alpha 2-gamma globulin region (Fig. 1, 1C) . Through the use of CIE, ALP activity was observed on the precipitin lines formed by anti-IgG or anti-C3c (Fig. 1, 1C, IC3c ). These findings indicated that ALP-IgG was associated with C3c. But, the light Counterimmunoelectrophoresis (CIE): Cellulose acetate membrane applied serum at the region indicated by Ag, and anti-human serum at the region indicated by Ab was electrophoresed at 140V fcr approximately 30min. After CIE, ALP activity on the membrane was visualized by incubation with 5-bromo-3-indolylphosphate (see text). SP, serum protein; C, control (anti-human serum was not applied); G, anti-IgG;
A, anti-IgA; M, anti-IgM; K, anti-kappa light chain; L, anti-lambda light chain; C3c, anticomplement C3c; Ag, antigen; Ab, antibody. 1. A 70-year-old male suffering from pancreatic cancer. Serum ALP, 349IU/l (normal range, 77-224IU/l). This serum was obtained on the 7th day after operation. ALP activity was observed on the precipitin lines formed by anti-IgG (G) or anti-C3c (C3c). These findings were seen for a few months after operation. 2. A 72-year-old male suffering from lung cancer. Serum ALP, 370IU/l. This serum was obtained about one month after operation. ALP activity was observed on the precipitin lines formed by anti-IgG (G) or anti-lambda light chain (L). These findings were seen for about 3 months after operation (till discharge), but ALP isozyme of this patient was not studied after discharge. chain of this bound IgG was not detected.
In the other case, the highest level of ALP activity was observed at the beta-gamma globulin region (Fig. 1, 2C) . By CIE, ALP activity was detected on the precipitin lines formed by antiIgG or anti-lambda light chain (Fig. 1, 2G, 2L ), but not on the psecipitin line formed by antiC3c, indicating ALP-IgG was not associated with C3c. Although data were not shown, none of these two cases were associate with C1q.
2) Gel filtration profile of ALP on
Sephacryl S-300 By gel filtration, two peaks of ALP activity were seen in both cases (Fig. 2) . In one case, ALP having an approximate molecular weight of 900kD (ALP-900kD) was separated from normal sized ALP having molecular weight of approximate 160kD
( Fig. 2-1 ). In the other case, ALP with a molecular weight of approximate 450kD (ALP-450kD) was seen as a macro ALP (Fig. 2-2) .
3) Other studies
Inhibition of ALP activity in ALP-900kD and ALP-450kD by L-homoarginine was 70% and 65% of the total, respectively. These macro ALPs showed little sensitivity to L-phenylalanine or We studied ALP-Ig from the viewpoint of the immune complex (IC) or circulating immune complex (CIC). The IC is metabolized by reticuloendothelial systems or macrophages, depending upon its size or solubility. Since macrophages have C3b receptors on their surfaces, the IC associated with C3b is eliminated from the circulation rapidly than IC without C3b.8,9) However, C3c receptors have not been demonstrated on any phagocytes, the IC with C3c may remain in the circulation for an extended period.
We studied ALP-Ig using anti-C3c, and demon- were detected, possibly as a result of two molecules of ALP being associate with one molecule of IgG. However, it remains to be elucidated whether ALP-IgG complex has other substanced than complement. ALP-450kD was proposed to consist of two ALP molecules and one IgG molecule or vice versa.
Results from amino acids inhibition assays, heat inactivation tests and ETA using monoclonal antibodies against human placental ALP, it was indicated that the ALP associated with both macro ALPs were tissue non-specific ALP. Heat stability was lower in ALP-900kD, but higher in ALP-450kD, compared to tissue non-specific ALP. Umeki et al. reported an increase in heat stability in the ALP-Ig of 900kD.5) But, the mechanisms responsible for the changes in that stability is unclear.
In the future, clinical significance of the interaction of ALP-Ig and complement should be investigated. 
